Kezdőlap Mélykutatási eredmények QA Jelek Területek Módszertan Névjegy Keresés Rákkutatás Publikációk, biológiai célpontok, gyógyszerek, bizonyítékszintek és klinikai vizsgálatok.
A rákkutatási terület evidencialétrát használ a sejtmodelltől a klinikai gyakorlatig. A rendszer kutatási tájékozódást ad, nem diagnosztizál és nem választ kezelést.
Jelek Relationship of modifiable risk factors with the incidence of thyroid cancer: a worldwide study — Thyroid cancerFrequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High‑Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study — NeuroblastomaClinical Outcomes, Patterns of Failure, and Salvage Therapies of a Large Modern Cohort of Patients With Anal Squamous Cell Carcinoma Treated With Definitive-Intent Intensity‑Modulated Radiation Therapy — Anal squamous cell carcinomaMachine learning for survival outcome in head and neck squamous cell carcinoma: a multicenter validation study — Head and neck squamous cell carcinomaIf It77s a Solid Tumor Target, It May Be a Hematologic Cancer Target: Bridging the Great Divide — CholangiocarcinomaHead and Neck Cancer Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer — Head and neck squamous cell carcinomaEffective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates — Acute myeloid leukemiaLung Cancer in Never-Smokers: Risk Factors, Driver Mutations, and Therapeutic Advances — NSCLCLoncastuximab in high‑risk and heavily pre‑treated relapsed/refractory diffuse large B‑cell lymphoma: a real‑world analysis from 21 US centers — Diffuse large B-cell lymphomaAn open‑label study of pemigatinib in cholangiocarcinoma: final results from FIGHT‑202 — CholangiocarcinomaRecent Advances in Cervical Cancer Treatment — Cervical cancerAdeno‑to‑Squamous Transition Drives Resistance to KRAS Inhibition in LKB1 Mutant Lung Cancer — NSCLCHepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment — Hepatocellular carcinomaChimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy — Colorectal cancerProstate‑Specific Antigen Screening and 15‑Year Prostate Cancer Mortality — Prostate cancerSurgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF‑RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF‑Cohort Trial) — Hepatocellular carcinomaPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer — Prostate cancerNeoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update — Ovarian cancerImmunotherapy for glioblastoma: current state, challenges, and future perspectives — GlioblastomaLymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results — Hepatocellular carcinomaElőző 60/102 Következő